Family Medicine & Primary Care Review
eISSN: 2449-8580
ISSN: 1734-3402
Family Medicine & Primary Care Review
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search

Open access

without publication fees
4/2025
vol. 27
 
Share:
Send email
Share:
Original paper

The overview of adverse events following immunization among Udayana University Hospital staff after receiving MPOX vaccination

Cokorda Agung Wahyu Purnamasidhi
1
,
David Christopher Tjandra
2
,
Ledwin Meikel Wibisono
2
,
Cokorda Agung Pratiwi
2
,
I G Mahapraja Divasta
2
,
Ni Kadek Fitria Parahita
,
Ida Ayu Sri Wijayanti
3
,
Dewa Putu Wisnu Wardhana
4
,
Brian Eka Rachman
5
,
Saktivi Harkitasari
6

  1. Tropical and Infectious Diseases Division, Internal Medicine Department, Udayana University Hospital, Bali, Indonesia
  2. Medical Faculty, Udayana University, Bali, Indonesia
  3. Department of Neurology, Udayana University Hospital, Bali, Indonesia
  4. Department of Neurosurgery, Udayana University Hospital, Bali, Indonesia
  5. Division of Tropical and Infectious Diseases, Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia
  6. Department of Neurology, Faculty of Medicine and Health Science, Warmadewa University, Bali, Indonesia
Family Medicine & Primary Care Review 2025; 27(4)
DOI: https://doi.org/10.5114/fmpcr.2025.156539
Online publish date: 2025/12/22
Article file
- 10 FM&PCR 4 25 - O - Purnamasidhi, Tjandra - 1786 - The overview.pdf  [0.35 MB]
Get citation
 
PlumX metrics:
 
1. Xiang Y, White A. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters. Emerg Microbes Infect 2022; 11(1): 1768–1777.
2. Sevindik M, Yazar M, Polat AO, et al. MONKEY POX (M-Pox/MPXV): Epidemiology, transmission, clinical findings, treatment and herbal treatment. Indian J Nat Prod Resour 2024; 15(4): 473–490.
3. CDC. Mpox in the United States and Around the World: Current Situation. cvc.gov. 2024. Available from URL: https://www.cdc.gov/mpox/situation-summary/index.html.
4. Beeson A, Styczynski A, Hutson CL, et al. Mpox respiratory transmission: the state of the evidence. Lancet Microbe 2023; 4(4): e277–e283.
5. Pischel L, Martini BA, Yu N, et al. Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis. Vaccine 2024; 42(25): 126053.
6. Saadh MJ, Ghadimkhani T, Soltani N, et al. Progress and prospects on vaccine development against monkeypox infection Mohamed. Microb Pathog 2023; 180: 106156.
7. Kriss JL, Boersma PM, Martin E, et al. Morbidity and Mortality Weekly Report Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox-United States. US Department of Health and Human Services/Centers for Disease Control and Prevention; 2022. Available from URL: https://www.cdc.gov/poxvirus/monkeypox/interim-
8. Kemenkes. Pedoman Pencegahan dan Pengendalian Penyakit Monkeypox. Vol. 1. Kementerian Kesehatan RI. 2022. Available from URL: https://dinkes.acehtenggarakab.go.id/media/2022.08/pedoman_pencegahan_dan_pengendalian_penyakit_monkeypox1.pdf (in Indonesian).
9. Setyoningsih H, Wicaksono TZ, Palupi DA. Identifikasi Kejadian Ikutan Pasca Imunisasi (KIPI) Vaksin Covid-19 pada Kelompok Komorbiditas di Desa Blaru Kecamatan Pati Kabupaten Pati. JPSCR J Pharm Sci Clin Res 2023; 8(3): 394 (in Indonesian).
10. Hadinegoro SRS. Kejadian Ikutan Pasca Imunisasi. Sari Pediatr 2016; 2(1): 2 (in Indonesian).
11. Garcia-Atutxa I, Mondragon-Teran P, Huerta-Saquero A, et al. Advancements in monkeypox vaccines development: a critical review of emerging technologies. Front Immunol 2024; 15: 1456060.
12. Ananda SA, Huda N, Putri SA. Hubungan Pengetahuan terkait Penyakit Monkeypox terhadap Kesediaan Perawat Melakukan Vaksinasi Monkeypox. J Ilm Permas J Ilm STIKES Kendal 2023; 13(4): 1351–1358 (in Indonesian).
13. Thy M, Peiffer-Smadja N, Mailhe M, et al. Breakthrough Infections after Postexposure Vaccination against Mpox. N Engl J Med 2022; 387(26): 2477–2499.
14. Montalti M, Di Valerio Z, Angelini R, et al. Safety of Monkeypox Vaccine Using Active Surveillance, Two-Center Observational Study in Italy. Vaccines 2023; 11(7): 1163.
15. Lim SY, Kim HS, Yim HS, et al. Comparison of Waning Antibody Responses After Natural Monkeypox Virus Infection and Mpox Vaccination Beyond 6 Months in South Korea. Open Forum Infect Dis 2024; 11(10): 1–4.
16. Sididi M. Gambaran Kejadian Ikutan Pasca Imunisasi (KIPI) Vaksin Sinovac Pada Siswa Di SMA Negeri 7 Luwu Utara Kecamatan Baebunta Selatan Kabupaten Luwu Utara. Wind Public Heal J 2022; 3(5): 824–834 (in Indonesian).
17. Kurniawati D, Yuwindry I, Sariyasih S. Gambaran Kejadian Ikutan Pasca Imunisasi (KIPI) Setelah Melakukan Vaksinasi Covid-19 Pada Masyarakat Banjarmasin Selatan. J Pharm Care Sci 2022; 2(2): 77–84 (in Indonesian).
18. AusVaxSafety. Mpox (monkeypox) vaccine. AusVaxSafety [Internet]. 2023 [cited 12.12.2024]. Available from URL: https://ausvaxsafety.org.au/vaccine-safety-data/mpox-monkeypox-vaccine.
19. Boom M, van der, Hunsel F, van. Adverse reactions following MPox (monkeypox) vaccination: An overview from the Dutch and global adverse event reporting systems. Br J Clin Pharmacol 2023; 89(11): 3302–3310, doi: 10.1111/bcp.15830.
20. Hunsel F, van, Gattepaille LM, Westerberg C, et al. Reports for Herbal Medicines in the Global Suspected ADR Database VigiBase. In: Barnes J. (ed.). Pharmacovigilance for Herbal and Traditional Medicines. Advances, Challenges and International Perspectives. Cham: Adis, doi: 10.1007/978-3-031-07275-8_16.
21. Mohapatra RK, Mishra S, Rabaan AA, et al. Monkeypox breakthrough infections and side-effects: Clarion call for nex-gen novel vaccine. New Microbes New Infect 2023; 52: 101084, doi: 10.1016/j.nmni.2023.101084.
22. Parnian R, Heydarifard F, Mousavi FS, et al. Innate Immune Response to Monkeypox Virus Infection: Mechanisms and Immune Escape. J Innate Immun 2024; 16(1): 413–424.
23. CDC. Monkeypox in the United States and Around the World: Current Situation. Available from URL: https://www.cdc.gov/mpox/situation-summary/index.html.
24. Valk ES, van der, Savas M, Rossum EFC, van. Stress and Obesity: Are There More Susceptible Individuals? Curr Obes Rep 2018; 7(2): 193–203.
25. Sykes EA, Wu V, Beyea MM, et al. Pharyngitis: Approach to diagnosis and treatment. Can Fam Physician 2020; 66(4): 251–257.
Copyright: © 2025 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.